EYPT – Knox Daily

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

EyePoint Pharmaceuticals Inc’s recently made public that its Director ANTHONY P. ADAMIS acquired Company’s shares for reported $0.67 million on

Stock Earnings

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

In a filing, EyePoint Pharmaceuticals Inc revealed its Director ANTHONY P. ADAMIS acquired Company’s shares for reported $0.67 million on

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals

Analysts Viewpoint

In a filing, EyePoint Pharmaceuticals Inc revealed its Director ANTHONY P. ADAMIS acquired Company’s shares for reported $0.67 million on

Stock Earnings

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

EyePoint Pharmaceuticals Inc’s recently made public that its Director ANTHONY P. ADAMIS acquired Company’s shares for reported $0.67 million on

News

The NASDAQ’s 1.0% gain led the market yesterday, and the S&P 500 and DJIA posted fractional gains. After passing its

News

The S&P 500 pulled back from its newly acquired all-time high yesterday and 0.4% on the session. The NASDAQ also

Tag: EYPT